Skip to content
2000
Volume 2, Issue 1
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

The majority of type 2 diabetic patients are overweight and any excess weight, or weight gain, adversely affects glycaemic control. Paradoxically, antidiabetic agents used to improve glycaemic control are frequently associated with weight gain, particularly insulin therapy. Such weight gain further deteriorates glycaemic control and increases insulin resistance. Understanding body weight regulation in type 2 diabetic patients is therefore necessary to better adapt for the effect of such medication on weight. Expressed in terms of energy, weight gain results from positive energy balance. Positive energy balance in type 2 diabetes is most usually attributed to decreased energy expenditure and the cessation of glycosuric energy loss following the initiation of hypoglycaemic treatment. It appears from current literature however that these two factors, even in combination, cannot completely explain observed weight gain. Indeed, the precise contribution of energy intake and appetite, a key determinant of energy intake, to this positive energy balance remains a black box. In this review the potential contribution of a change in feeding regimen to weight gain associated with insulin treatment is assessed, with particular attention being paid to insulin's effect within the brain.

Loading

Article metrics loading...

/content/journals/cnf/10.2174/157340106775471958
2006-02-01
2024-11-26
Loading full text...

Full text loading...

/content/journals/cnf/10.2174/157340106775471958
Loading

  • Article Type:
    Research Article
Keyword(s): diabetes; energy intake; insulin; Weight gain
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test